Dr. Philip Beer

Director

Dr Philip Beer is a physician scientist and precision oncology specialist who holds diverse roles across the healthcare, academic and commercial sectors. Philip provides clinical cancer genomics support to healthcare improvement projects, including the NHS, and to drug discovery and development ventures in academia and industry. Philip is part of the International Cancer Genome Consortium (ICGC) management team, the Friends of Cancer Research TMB working group and the forthcoming Precision FDA TMB challenge. These projects are unified by a singular goal of leveraging genomic technologies to improve outcomes for cancer patients, and are underpinned by a portfolio of research focused on linking cancer biology and genomics, delivered through honorary positions at the Sanger Institute, UK, and Mayo Clinic, USA.